{"id":8297,"date":"2019-02-13T14:56:48","date_gmt":"2019-02-13T19:56:48","guid":{"rendered":"https:\/\/blog.brainstation.io\/?p=8297"},"modified":"2019-02-13T14:56:48","modified_gmt":"2019-02-13T19:56:48","slug":"what-bostons-bioboom-means-for-the-city","status":"publish","type":"post","link":"https:\/\/brainstation.io\/blog\/what-bostons-bioboom-means-for-the-city","title":{"rendered":"What Boston\u2019s BioBoom Means for the City"},"content":{"rendered":"

To call Boston a hub for biotech would almost be an understatement. After all, the biotech industry can trace its roots to the Boston area \u2013 Cambridge specifically \u2013 with Beantown standing alongside San Francisco as the first places biotech began gathering major momentum in the 1980s and \u201890s. Now, the Boston area houses <\/span>more than 1,100<\/span><\/a> biotech and biopharma companies, academic centers, and life-science organizations. <\/span><\/p>\n

The amazing thing, then, is that even with Boston\u2019s deeply established history, the Massachusetts city\u2019s biotech industry has never been hotter.<\/span><\/p>\n

We took a closer look at this “BioBoom”\u00a0 and what it might mean for the city\u2019s future.<\/span><\/p>\n

Jobs Abound, and Employers are Competing Over the Best Candidates<\/b><\/h2>\n

A look at the sheer number of people employed in Massachusetts\u2019 biotech industry illustrates just how rapid the recent growth has been, fueled largely by the vast expansion of the city\u2019s biopharma industry.<\/span><\/p>\n

Biotech industry jobs grew by <\/span>28 percent<\/span> from 2008 to 2017, and by 4.3 percent in that final year alone. Industry employees \u2013 a number that <\/span>surpassed 70,000<\/span> in 2018 \u2013 averaged a steep annual wage of $149,731, meaning the Massachusetts biotech workforce brought home $10.4 billion total.<\/span><\/p>\n

In that environment, those working in Boston\u2019s biotech industry aren\u2019t just finding high wages and abundant opportunity, but other incentives.<\/span><\/p>\n

According to the <\/span>Boston Globe<\/span>, perks offered in the local biotechnology sector include 100 percent company-paid health insurance, unlimited vacation, free catered lunches, and money to pay back student loans. <\/span><\/p>\n

Neon Therapeutics<\/span><\/a>, a startup developing cancer vaccines, offers its employees Friday afternoons off in the summer, weekly messages, extensive dental insurance, and a \u201clife services concierge\u201d who can offer help with all sorts of tasks, like finding a dog walker or a solid financial planner.<\/span><\/p>\n

\u201cWhen we make a job offer to an employee, they have three other offers that they\u2019re considering,\u201d Teresa Regan, Vice-President of Human Resources at Neon, told the Globe. <\/span><\/p>\n

\u201cWe do the benefits because it\u2019s competitive, but also because we think it\u2019s the right thing to do.\u201d<\/span><\/p>\n

Venture Funding is High and Still Rising<\/b><\/h2>\n

Venture investment in Massachusetts biopharma companies in 2017 was <\/span>$3.1 billion <\/span>\u2013 meaning 37 percent of all biopharma VC dollars went to companies in that state. In the first two quarters of 2018 alone, the biopharma industry raised another $2.7 billion. Combining biopharma with life sciences companies, Massachusetts-based organizations raised $3.6 billion in VC investment in 2017.<\/span><\/p>\n

There are plenty of recent examples to choose from. <\/span>Relay Therapeutics<\/span><\/a> recently secured $400 million in Series C financing, Medicare Advantage business <\/span>Devoted Health<\/span><\/a> raised $300 million in a Series B round in fall 2018, while <\/span>WuXI NextCODE<\/span><\/a> \u2013 a global platform for genomic data \u2013 announced the completion of $200 million in Series C financing in November 2018. And in October, Bain Capital and Pfizer announced the creation of the Boston-based <\/span>Cerevel Therapeutics<\/span><\/a>, devoted to developing drugs for central nervous system disorders, with a $350 million funding commitment.<\/span><\/p>\n

Although significant investment pours in from outside \u2013 in 2017, 60 percent of investment in Massachusetts biopharma companies came from out of state \u2013 it helps that there are well-established venture capital firms locally. <\/span>F-Prime Capital<\/span><\/a> (formerly Fidelity Biosciences), for instance, was among the first VC companies to focus on \u201cbiopharmaceuticals, medtech, and healthcare IT\/services.\u201d<\/span><\/p>\n

Some investors view the Boston market as a well-kept secret.<\/span><\/p>\n

\u201cBoston often gets dismissed as a has-been startup city. But the successes are often overlooked and don\u2019t get the same attention as less successful, but more hypey companies in San Francisco,\u201d Blake Bartlett, a partner at Boston-based venture firm\u00a0<\/span>OpenView<\/span><\/a>, told\u00a0Crunchbase News.<\/span><\/p>\n

Major Exits<\/b><\/h2>\n

Some of the most high-profile recent exits in Massachusetts have been focused in the biotech industry.<\/span><\/p>\n

In a deal that was deemed to be \u201c<\/span>already shaking up the drugstore industry<\/span><\/a>,\u201d Amazon acquired the online pharmacy <\/span>PillPack<\/span><\/a> for just under $1 billion in June 2018. <\/span>Moderna Therapeutics<\/span><\/a> also recently made headlines with a historic IPO in which it raised $600 million \u2013 the largest amount in biotech history \u2013 to set up a roughly $7.5 billion valuation.<\/span><\/p>\n

In other major recent acquisitions and IPOs, <\/span>Teledoc<\/span><\/a> spent $440 million to acquire digital healthcare company <\/span>Best Doctors<\/span><\/a> in 2017, while <\/span>Rubius Therapeutics<\/span><\/a> raised $241 million in IPO in July 2018 \u2013 a record until it was surpassed by Moderna.<\/span><\/p>\n

More Companies Are Coming to Town<\/b><\/h2>\n

Seemingly, Boston\u2019s BioBoom is only attracting more biotech companies to town.<\/span><\/p>\n

Many big pharmaceutical and medical companies \u2013 including Genzyme, Novartis,\u00a0and Baxter \u2013 are doing as Pfizer did and looking to Boston\u2019s startups to handle R&D for a lower cost. Unsurprisingly, Boston was also announced as the home for the still-unnamed but closely watched new healthcare venture from Amazon, Berkshire Hathaway, and JPMorgan.<\/span><\/p>\n

In fact, over <\/span>12 million square feet<\/span><\/a> of commercial lab space has been added to Massachusetts from 2009 to 2018, representing a 71 percent increase.<\/span><\/p>\n

Government support has helped that growth along. In fact, in 2017, <\/span>more than 10 percent<\/span><\/a> of all National Institutes of Health funding went to Massachusetts organizations, making the state by far the leader in funding per capita at $396 \u2013 far more than second-place Maryland at $266. Five of the top six NIH-funded hospitals are in Boston, and Massachusetts receives 57 percent of all NIH funding to independent hospitals.<\/span><\/p>\n

That base of hospitals \u2013 as well as the Boston area\u2019s litany of famed educational institutions \u2013 presents a glut of opportunities for research, another reason Massachusetts is such a popular location for biotech.<\/span><\/p>\n

What it Means for the Future of Boston<\/b><\/h2>\n

It\u2019s natural to be skeptical about whether this level of growth can be sustained, but there are plenty of encouraging signs.<\/span><\/p>\n

Every year, <\/span>FierceBiotech<\/span><\/a> publishes the Fierce 15 list of the world\u2019s most promising biotech companies.<\/span><\/p>\n

In 2018\u2019s list, six of the 15 companies were based in the greater Boston area, including <\/span>Arrakis Therapeutics<\/span><\/a>, <\/span>Beam Therapeutics<\/span><\/a>, <\/span>Jnana Therapeutics<\/span><\/a>, <\/span>Kronos Bio<\/span><\/a>, <\/span>Pandion Therapeutics<\/span><\/a>, and <\/span>Compass Therapeutics<\/span><\/a>.<\/span><\/p>\n

That was hardly an anomaly; Boston-area startups claimed six of 15 spots in 2017 and 2016 as well. <\/span><\/p>\n

Although Boston\u2019s biotech and biopharma industries will face the same growing pains that challenge any city where rapid growth occurs, those on the inside are optimistic that the foundation is in place for Boston as a biotech hub for a long time to come.<\/span><\/p>\n

\u201cWe often hear of obstacles that might face large companies when considering Boston as a growth platform \u2014 high costs for labor, taxes, and rent. But Boston has shown that, in the global competition for biotech and pharmaceutical jobs, we can compete successfully,\u201d wrote biomedical entrepreneur <\/span>Christoph Westphal<\/span>.<\/span><\/p>\n

\u201cOther cities that vie with us \u2014 San Francisco, London, Paris, the New York\/New Jersey region, cities in Switzerland or Germany \u2014 often have more significant hurdles of their own. In health care, we have shown that Boston can be a key global player. We look forward to the day when this is also true for other innovation-based industries.\u201d<\/span><\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

The Boston area now has more than 1,100 biotech and biopharma companies, academic centers, and life-science organizations.<\/p>\n","protected":false},"author":7,"featured_media":8298,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[698,533],"tags":[762,761,699],"yoast_head":"\nWhat Boston\u2019s BioBoom Means for the City<\/title>\n<meta name=\"description\" content=\"The Boston area houses more than 1,100 biotech and biopharma companies, academic centers, and life-science organizations. We took a closer look at this "BioBoom"\u00a0and what it might mean for the city\u2019s future.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brainstation.io\/blog\/what-bostons-bioboom-means-for-the-city\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"What Boston\u2019s BioBoom Means for the City\" \/>\n<meta property=\"og:description\" content=\"The Boston area houses more than 1,100 biotech and biopharma companies, academic centers, and life-science organizations. We took a closer look at this "BioBoom"\u00a0and what it might mean for the city\u2019s future.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brainstation.io\/blog\/what-bostons-bioboom-means-for-the-city\" \/>\n<meta property=\"og:site_name\" content=\"BrainStation\u00ae Blog\" \/>\n<meta property=\"article:published_time\" content=\"2019-02-13T19:56:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/d2re7sjnpekmig.cloudfront.net\/prod\/wp-content\/uploads\/2019\/02\/Zachary_Monteiro_Boston_Bio_Boom.png\" \/>\n\t<meta property=\"og:image:width\" content=\"3331\" \/>\n\t<meta property=\"og:image:height\" content=\"1149\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BrainStation\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brainstation.io\/blog\/#website\",\"url\":\"https:\/\/brainstation.io\/blog\/\",\"name\":\"BrainStation\u00ae Blog\",\"description\":\"The Digital Learning Company\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brainstation.io\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/brainstation.io\/blog\/what-bostons-bioboom-means-for-the-city#primaryimage\",\"url\":\"https:\/\/d2re7sjnpekmig.cloudfront.net\/prod\/wp-content\/uploads\/2019\/02\/Zachary_Monteiro_Boston_Bio_Boom.png\",\"contentUrl\":\"https:\/\/d2re7sjnpekmig.cloudfront.net\/prod\/wp-content\/uploads\/2019\/02\/Zachary_Monteiro_Boston_Bio_Boom.png\",\"width\":3331,\"height\":1149,\"caption\":\"Boston's Biotech Industry\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brainstation.io\/blog\/what-bostons-bioboom-means-for-the-city#webpage\",\"url\":\"https:\/\/brainstation.io\/blog\/what-bostons-bioboom-means-for-the-city\",\"name\":\"What Boston\u2019s BioBoom Means for the City\",\"isPartOf\":{\"@id\":\"https:\/\/brainstation.io\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/brainstation.io\/blog\/what-bostons-bioboom-means-for-the-city#primaryimage\"},\"datePublished\":\"2019-02-13T19:56:48+00:00\",\"dateModified\":\"2019-02-13T19:56:48+00:00\",\"author\":{\"@id\":\"https:\/\/brainstation.io\/blog\/#\/schema\/person\/9f37983a6c4da6cf5dd422481ac8cf11\"},\"description\":\"The Boston area houses more than 1,100 biotech and biopharma companies, academic centers, and life-science organizations. We took a closer look at this \\\"BioBoom\\\"\u00a0and what it might mean for the city\u2019s future.\",\"breadcrumb\":{\"@id\":\"https:\/\/brainstation.io\/blog\/what-bostons-bioboom-means-for-the-city#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brainstation.io\/blog\/what-bostons-bioboom-means-for-the-city\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brainstation.io\/blog\/what-bostons-bioboom-means-for-the-city#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brainstation.io\/blog\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"What Boston\u2019s BioBoom Means for the City\"}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/brainstation.io\/blog\/#\/schema\/person\/9f37983a6c4da6cf5dd422481ac8cf11\",\"name\":\"BrainStation\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/brainstation.io\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/80c14b8388838ae1453aec36606b232d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/80c14b8388838ae1453aec36606b232d?s=96&d=mm&r=g\",\"caption\":\"BrainStation\"},\"description\":\"BrainStation is a global leader in digital skills training, empowering businesses and brands to succeed in the digital age. Established in 2012, BrainStation has worked with over 250 instructors from the most innovative companies, developing cutting-edge, real-world digital education that has empowered more than 50,000 professionals and some of the largest corporations in the world.\",\"url\":\"https:\/\/brainstation.io\/blog\/author\/brainstation\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"What Boston\u2019s BioBoom Means for the City","description":"The Boston area houses more than 1,100 biotech and biopharma companies, academic centers, and life-science organizations. We took a closer look at this \"BioBoom\"\u00a0and what it might mean for the city\u2019s future.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brainstation.io\/blog\/what-bostons-bioboom-means-for-the-city","og_locale":"en_US","og_type":"article","og_title":"What Boston\u2019s BioBoom Means for the City","og_description":"The Boston area houses more than 1,100 biotech and biopharma companies, academic centers, and life-science organizations. We took a closer look at this \"BioBoom\"\u00a0and what it might mean for the city\u2019s future.","og_url":"https:\/\/brainstation.io\/blog\/what-bostons-bioboom-means-for-the-city","og_site_name":"BrainStation\u00ae Blog","article_published_time":"2019-02-13T19:56:48+00:00","og_image":[{"width":3331,"height":1149,"url":"https:\/\/d2re7sjnpekmig.cloudfront.net\/prod\/wp-content\/uploads\/2019\/02\/Zachary_Monteiro_Boston_Bio_Boom.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Written by":"BrainStation","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/brainstation.io\/blog\/#website","url":"https:\/\/brainstation.io\/blog\/","name":"BrainStation\u00ae Blog","description":"The Digital Learning Company","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brainstation.io\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/brainstation.io\/blog\/what-bostons-bioboom-means-for-the-city#primaryimage","url":"https:\/\/d2re7sjnpekmig.cloudfront.net\/prod\/wp-content\/uploads\/2019\/02\/Zachary_Monteiro_Boston_Bio_Boom.png","contentUrl":"https:\/\/d2re7sjnpekmig.cloudfront.net\/prod\/wp-content\/uploads\/2019\/02\/Zachary_Monteiro_Boston_Bio_Boom.png","width":3331,"height":1149,"caption":"Boston's Biotech Industry"},{"@type":"WebPage","@id":"https:\/\/brainstation.io\/blog\/what-bostons-bioboom-means-for-the-city#webpage","url":"https:\/\/brainstation.io\/blog\/what-bostons-bioboom-means-for-the-city","name":"What Boston\u2019s BioBoom Means for the City","isPartOf":{"@id":"https:\/\/brainstation.io\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/brainstation.io\/blog\/what-bostons-bioboom-means-for-the-city#primaryimage"},"datePublished":"2019-02-13T19:56:48+00:00","dateModified":"2019-02-13T19:56:48+00:00","author":{"@id":"https:\/\/brainstation.io\/blog\/#\/schema\/person\/9f37983a6c4da6cf5dd422481ac8cf11"},"description":"The Boston area houses more than 1,100 biotech and biopharma companies, academic centers, and life-science organizations. We took a closer look at this \"BioBoom\"\u00a0and what it might mean for the city\u2019s future.","breadcrumb":{"@id":"https:\/\/brainstation.io\/blog\/what-bostons-bioboom-means-for-the-city#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brainstation.io\/blog\/what-bostons-bioboom-means-for-the-city"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brainstation.io\/blog\/what-bostons-bioboom-means-for-the-city#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brainstation.io\/blog"},{"@type":"ListItem","position":2,"name":"What Boston\u2019s BioBoom Means for the City"}]},{"@type":"Person","@id":"https:\/\/brainstation.io\/blog\/#\/schema\/person\/9f37983a6c4da6cf5dd422481ac8cf11","name":"BrainStation","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/brainstation.io\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/80c14b8388838ae1453aec36606b232d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80c14b8388838ae1453aec36606b232d?s=96&d=mm&r=g","caption":"BrainStation"},"description":"BrainStation is a global leader in digital skills training, empowering businesses and brands to succeed in the digital age. Established in 2012, BrainStation has worked with over 250 instructors from the most innovative companies, developing cutting-edge, real-world digital education that has empowered more than 50,000 professionals and some of the largest corporations in the world.","url":"https:\/\/brainstation.io\/blog\/author\/brainstation"}]}},"_links":{"self":[{"href":"https:\/\/brainstation.io\/blog\/wp-json\/wp\/v2\/posts\/8297"}],"collection":[{"href":"https:\/\/brainstation.io\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brainstation.io\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brainstation.io\/blog\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/brainstation.io\/blog\/wp-json\/wp\/v2\/comments?post=8297"}],"version-history":[{"count":1,"href":"https:\/\/brainstation.io\/blog\/wp-json\/wp\/v2\/posts\/8297\/revisions"}],"predecessor-version":[{"id":8299,"href":"https:\/\/brainstation.io\/blog\/wp-json\/wp\/v2\/posts\/8297\/revisions\/8299"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/brainstation.io\/blog\/wp-json\/wp\/v2\/media\/8298"}],"wp:attachment":[{"href":"https:\/\/brainstation.io\/blog\/wp-json\/wp\/v2\/media?parent=8297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brainstation.io\/blog\/wp-json\/wp\/v2\/categories?post=8297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brainstation.io\/blog\/wp-json\/wp\/v2\/tags?post=8297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}